226 filings
Page 5 of 12
F-3
erlgxtv6
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K
8in vc7j1xvl
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
sdssukums
29 Oct 21
ObsEva Announces Management Change
5:24pm
6-K/A
fnru7zipr 1a0hnk7
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
hxa6bkqk82an09o
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
s7uxjo2ifekdtz
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
yjlcskjtgj8kghiba
27 Jul 21
Current report (foreign)
6:12am
6-K
6cyell80andhmuab
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
6-K
4kg1dvnr7oehhzg g1
25 May 21
ObsEva Announces Proposed Changes to the Composition of its
5:22pm
6-K
ocszhx z9
20 May 21
ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of
6:30am
6-K
yf2tab
6 May 21
ObsEva appoints Clive Bertram as Chief Commercial Officer
6:05am
6-K
fber0w
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
gr59q
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
ptu7808wy86vygvkunp
31 Mar 21
Current report (foreign)
7:15am
6-K
jf6vwbenvt8 d6
5 Mar 21
Current report (foreign)
8:15am
424B5
jbraz5bm3c7rgf1e
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
u069qjxs r61bv
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
2shfd1 dc0f07
17 Feb 21
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
6:04am
6-K
c5ab2u3iiowtsarq
11 Feb 21
ObsEva to Increase Issued Share Capital by Creating Additional Treasury Shares
6:08am